CCOP/NCORP / LAPS ASA / Network Groups / Canadian Collaborating Clinical Trials Network Group / Lead Academic Participating Site Affiliates / LAPS SA / Lead Academic Participating Site Aligned Affiliates / NCI NETWORK GROUPS AND CCOP/NCORP / Lead NCTN Group / /
Country
United States / /
Event
Product Issues / Product Recall / FDA Phase / /
Facility
National Cancer Institute / Pharmacy Review / Pharmacy Operations / American College of Radiology Imaging Network / Institute of Medicine / /
IndustryTerm
cancer prevention / community site / quality control systems / Cancer Therapy / cancer care / integrated healthcare systems / data management / cancer imaging science / Cancer Treatment / proposed audit / /
MedicalCondition
cancer / Lesser Deficiency / diseases / /
MedicalTreatment
Cancer Therapy / /
Organization
National Cancer Institute / Congress / Division of Cancer Treatment and Diagnosis / Clinical Trials Monitoring Branch Cancer Therapy Evaluation Branch Division of Cancer Treatment and Diagnosis National Cancer Institute Revised / Food and Drug Administration / Division of Cancer Prevention / Institute of Medicine / NCI’s Cancer Trials Support Unit / the American College / Johns Hopkins Bloomberg School of Public Health / NCI NCTN / Center for Clinical Trials / /
Person
Affiliate / /
Position
Investigator / professor of epidemiology and founding director / Major / General / /
Product
date with the Group / Investigational New Drug / /
NCI GUIDELINES FOR AUDITING CLINICAL TRIALS FOR THE NCI NATIONAL CLINICAL TRIALS NETWORK (NCTN) PROGRAM, COMMUNITY CLINICAL ONCOLOGY PROGRAM (CCOP) / NCI COMMUNITY ONCOLOGY RESEARCH PROGRAM (NCORP) AND RESEARCH BASES